Brand-name medication guide
Learn how Zepbound differs from tirzepatide, Mounjaro, and compounded products, plus WellForm local, virtual, LillyDirect, and payment steps.
Zepbound is the tirzepatide brand for chronic weight management.
Mounjaro contains tirzepatide but is approved for type 2 diabetes, not as a weight-management synonym.
Fulfillment and savings, including LillyDirect when eligible, are confirmed separately from the WellForm care fee.
The decision in plain language
Zepbound and Mounjaro contain tirzepatide, but their FDA-approved indications differ. WellForm keeps the brand, indication, prescription destination, and payment process explicit.
Zepbound is the brand; tirzepatide is the active ingredient.
Mounjaro is a separate tirzepatide brand approved for type 2 diabetes.
Compounded tirzepatide is not FDA-approved and is not generic Zepbound.
WellForm care and pharmacy medication payment are separate.
A Zepbound request does not guarantee candidacy, a prescription, LillyDirect eligibility, supply, savings, or a weight-loss result.
Your care path
WellForm evaluates and manages medical care. If Zepbound is prescribed, the prescription goes to the confirmed pharmacy channel, which handles medication payment and dispensing.
Choose Ankeny or virtual care and tell us the option you want to discuss.
Review goals, history, current treatment, risks, and practical access.
Clarify the exact service or product, care fee, pharmacy path, and what is not included.
Monitor response, barriers, tolerability when relevant, and the next clinical or practical step.
Ready when you are
FDA-approved brand · LillyDirect may apply · $150 virtual / $300 Ankeny
What happens next
The consultation, payment explanation, and follow-up plan remain visible before you commit.
Select the page-specific interest when you request an Ankeny or virtual visit.
Dr. Patrick Oben reviews clinical fit and explains the differences that matter.
Agree on the care setting, WellForm fee, and any separate pharmacy transaction.
Clinical fit
Clinical history, goals, contraindications, current medication, and official Zepbound information are reviewed before authorization.
Ongoing care
The care setting changes the WellForm support experience; it does not change who dispenses and charges for the medication.
Benefits and limits
A Zepbound request does not guarantee candidacy, a prescription, LillyDirect eligibility, supply, savings, or a weight-loss result.
Compare your options
The ingredient and Mounjaro pages explain why shared tirzepatide does not make products or approved uses interchangeable.
Local, virtual, and payment
WellForm medical or support care is one transaction. A prescribed medication is generally a separate transaction with the dispensing pharmacy.
WellForm’s virtual medical-management fee. Zepbound is paid separately to LillyDirect or the dispensing pharmacy.
WellForm’s in-person support fee. Depending on the selected medical weight-loss pathway, clinic support can include InBody scans, UltraSlim red-light support, Ballancer lymphatic care, Power Plate, nutrition guidance, and optional Quest laboratory work when clinically appropriate. Zepbound is paid separately.
You pay LillyDirect, not WellForm. Current self-pay is $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5–15 mg under the Self Pay Journey Program when refilled within 45 days. Coverage, savings, supply, and a prescription are not guaranteed.
Before you request care
FDA-approved brand
FDA-approved brand · LillyDirect may apply · $150 virtual / $300 Ankeny
Evidence and authority
Current prescribing information and LillyDirect define the product and manufacturer fulfillment options. WellForm’s verified business facts define its medical-care fees.
Official resources
Still comparing?
WellForm can clarify the page, visit type, and information to bring without promising treatment before evaluation.
FAQ
Clear answers to the questions most likely to affect your decision.
A responsible next step
Request a physician visit, then confirm the exact prescription destination and separate pharmacy payment before treatment begins.
